Shandong Wit Dyne Health(000915.SZ) subsidiary obtains a drug registration certificate.

Huatai Dain (000915.SZ) announced that its subsidiary, Shandong Dain Marine Bio-pharmaceutical Co., Ltd. (referred to as Dain Pharmaceutical), has received the "Drug Registration Certificate" issued by the National Medical Products Administration. The drug's name is: Methylphenidate Hydrochloride Extended-Release Tablets. This product is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6-17 years as a monotherapy or as an adjunct to central stimulant therapy.